Robert Charles Jahr
Chief Executive Officer, Director · Outlook Therapeutics, Inc.
- 2025
- Aug 15, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Charles Jahr files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ghiath M. Sukhtian - $7.50M in OTLK purchases and sales in the last 12 months
- Kurt J. Hilzinger - $177K in OTLK purchases and sales in the last 12 months
- Faisal Ghiath Sukhtian - $150K in OTLK purchases and sales in the last 12 months
- Yezan Munther Haddadin - $39K in OTLK purchases and sales in the last 12 months
- Randy H. Thurman - $2K in OTLK purchases and sales in the last 12 months
- Lawrence A. Kenyon - OTLK
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Charles Jahr?
Robert Charles Jahr is a corporate insider, tracked as Chief Executive Officer, Director of Outlook Therapeutics, Inc. (OTLK). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert Charles Jahr submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Robert Charles Jahr been buying or selling stock?
Recorded transactions: 2 open-market purchases and 0 open-market sales across all tracked filings.
